Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 12/20 | 1.00 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.75 |
| ▸ | MMP12 | P39900 | 3/20 | 0.72 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.72 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | MMP13 | P45452 | 2/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | RXRA | P19793 | 1/20 | 0.59 |
| ▸ | RXRB | P28702 | 1/20 | 0.59 |
| ▸ | RXRG | P48443 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 1/20 | 0.58 |
| ▸ | MMP9 | P14780 | 1/20 | 0.58 |
| ▸ | MMP14 | P50281 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8618654 | 1.00 | FFAR1 (1.00) | FFAR1KEAP1MMP12FFAR4ABCC4 | |
| SCHEMBL7630944 | 0.98 | FFAR1 (0.96) | FFAR1KEAP1MMP12FFAR4ABCC4 | |
| Hydrochloric Acid SCHEMBL5753893 | 0.98 | FFAR1 (0.96) | FFAR1KEAP1MMP12FFAR4ABCC4 | |
| Biphenyl SCHEMBL31099230 | 0.93 | FFAR1 (0.88) | FFAR1KEAP1MMP12FFAR4AKR1B1 | |
| SCHEMBL14066660 | 0.93 | FFAR1 (0.87) | FFAR1KEAP1MMP12FFAR4LMNA | |
| SCHEMBL3533619 | 0.93 | FFAR1 (0.87) | FFAR1KEAP1MMP12FFAR4LMNA | |
| Biphenyl SCHEMBL31099239 | 0.91 | FFAR1 (0.84) | FFAR1KEAP1MMP12FFAR4AKR1B1 | |
| Biphenyl SCHEMBL27323905 | 0.91 | FFAR1 (0.84) | FFAR1KEAP1MMP12FFAR4AKR1B1 | |
| SCHEMBL12646566 | 0.90 | FFAR1 (0.81) | FFAR1KEAP1MMP12FFAR4 | |
| SCHEMBL279537 | 0.89 | FFAR1 (0.79) | FFAR1KEAP1MMP12FFAR4ABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570597-B2 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | XIAMEN UNIVERSITY (CN) | 2026-03-10 | — | — | US | claimed |
| CN-115772081-B | Preparation method of 4-ethoxy-2-methyl alkenyl butyraldehyde | 万华化学集团营养科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| US-20230348354-A1 | POLYARYL CARBOXYLIC FULLERENE DERIVATIVE AND USE THEREOF IN ANTI-CORONAVIRUS INFECTION | XIAMEN UNIVERSITY (CN) | 2023-11-02 | — | — | US | claimed |
| CN-116924906-A | Novel long-acting FFA1 agonist, preparation method thereof and application thereof as medicine | 广东药科大学 | 2023-10-24 | — | — | CN | claimed |
| CN-115772081-A | Preparation method of 4-ethoxy-2-methylal | 万华化学集团股份有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-114075105-B | Fullerene aryl polycarboxylic acid derivative and application thereof in resisting coronavirus infection | 厦门大学 | 2023-01-10 | — | — | CN | claimed |
| CN-114075105-A | Fullerene aryl polycarboxylic acid derivative and application thereof in resisting coronavirus infection | 厦门大学 | 2022-02-22 | — | — | CN | claimed |
| CN-101094827-B | Benzene compound having two or more substituents | DAIICHI SANKYO CO LTD | 2012-06-13 | — | — | CN | claimed |
| CN-101774941-A | Method for preparing and splitting 2-acyl amino-3-biphenylyl propionic acid | ZHEJIANG JIUZHOU PHARMACEUTICA | 2010-07-14 | — | — | CN | claimed |
| CN-101094827-A | Benzene compound having two or more substituents | SANKYO CO (JP) | 2007-12-26 | — | — | CN | claimed |
| EP-1438310-B1 | BETA-CARBOLIN DERIVATIVES AS PTP-INHIBITORS | TRANSTECH PHARMA INC (US) | 2006-12-20 | — | — | EP | claimed |
| US-6933303-B2 | Heteroaryl-fused nitrogen heterocycles as therapeutic agents | TRANSTECH PHARMA, INC. (US) | 2005-08-23 | — | — | US | claimed |
| EP-1438310-A1 | BETA-CARBOLIN DERIVATIVES AS PTP-INHIBITORS | TransTech Pharma Inc. (US) | 2004-07-21 | — | — | EP | claimed |
| US-20040014778-A1 | Heteroaryl - fused nitrogen heterocycles as therapeutic agents | VTVX HOLDINGS I LLC | 2004-01-22 | — | — | US | claimed |
| WO-2003033496-A1 | BETA-CARBOLIN DERIVATIVES AS PTP-INHIBITORS | TRANSTECH PHARMA, INC. (US) | 2003-04-24 | — | — | WO | claimed |
| EP-0850221-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1998-07-01 | — | — | EP | claimed |
| WO-1997008145-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1997-03-06 | — | — | WO | claimed |
| US-12570597-B2 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | XIAMEN UNIVERSITY (CN) | 2026-03-10 | — | — | US | disclosed |
| US-4342756-A | AS ANTITHROMBOTIC AGENTS AND ANTIASTHMATIC AGENTS | GLAXO GROUP LIMITED (GB) | 1982-08-03 | — | — | US | disclosed |
| US-4053639-A | 2-(2,2' OR 2,2'-FLUORO OR DIFLUORO-4-BIPHENYLYL)PROPAN-1-OL; ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC | THE BOOTS COMPANY LIMITED (EN) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014778-A1 | Heteroaryl - fused nitrogen heterocycles as therapeutic agents | PTPRG, PTPRM, PTPRC | FFAR1 1889/4885KEAP1 1953/4885MMP12 337/4885 |
| US-12570597-B2 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | SARS1, CCR1, CCR3 | FFAR1 313/4885KEAP1 2700/4885MMP12 3025/4885 |
| US-20230348354-A1 | POLYARYL CARBOXYLIC FULLERENE DERIVATIVE AND USE THEREOF IN ANTI-CORONAVIRUS INFECTION | SARS1, CRHR1, ACE2 | FFAR1 62/4885KEAP1 4003/4885MMP12 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.